Articles by Tom von Gunden
-
Halting HAE Attacks Via Oral Delivery With Pharvaris' Wim Souverijns And Stefan Abele
3/20/2025
In this episode of Sit and Deliver, host Tom von Gunden talks with Chief Commercial Officer Wim Souverijns and Chief Technical Operations Officer Stefan Abele from Pharvaris, a developer of orally administered treatments for hereditary angioedema, or HAE.
-
Formulations, Devices, Regulations, and Patients: Two Takes On Drug Delivery Trends
3/14/2025
In this unique episode of In Combination, series host Tom von Gunden, Chief Editor at Drug Delivery Leader, puts himself in combination with DDL Executive Editor Fran DeGrazio as the two share perspectives on drug delivery trends.
-
Considering Human Factors In Combination Product Design And Use
3/7/2025
In this episode of The Combination Products Handbook: The Series, host Tom von Gunden discusses Chapter 7 on human factors engineering (HFE) from The Combination Products Handbook: A Practical Guide for Combination Products and Other Combined Use Systems (CRC Press) with the chapter’s co-authors.
-
Deploying Immunologic Viral Agents To Target Cancers With Oncolytics Biotech's Thomas Heineman
2/27/2025
In this episode of Sit and Deliver, host Tom von Gunden talks with Oncolytics Biotech’s Chief Medical Officer Thomas Heineman about deploying oncolytic viral agents to ensure successful arrival at lymph nodes and at primary and metastatic tumor sites.
-
Scaling Platform Delivery Of Gene Therapies With NewBiologix's Igor Fisch
2/25/2025
Gene therapies aim to treat the root causes of disease rather than merely the symptoms. In this episode of Supplier Horizons, host Tom von Gunden talks with CEO Igor Fisch of NewBiologix, a developer of AAV-based gene therapy platform technologies.
-
Managing Risk When Developing Combination Products
2/20/2025
In this episode of The Combination Products Handbook: The Series, host Tom von Gunden discusses Chapter 6 on risk management from The Combination Products Handbook: A Practical Guide for Combination Products and Other Combined Use Systems (CRC Press) with the book’s editor, Susan Neadle, and chapter co-author Edwin Bills.
-
Bolstering Bowel And Bladder Control With Dignify Therapeutics' Karl Thor
2/6/2025
In this episode of Sit and Deliver, host Tom von Gunden talks with Chief Scientific Officer Karl Thor of Dignify Therapeutics about providing relief for patients suffering from neurogenic bowel and bladder dysfunction.
-
Developing A Combination Product: Early-Stage Formulation And Device Considerations At GSK
2/5/2025
Successful development of a safe and effective combination product depends on careful consideration of factors impacting the alignment between drug formulation and delivery device. In this episode of In Combination, host Tom von Gunden combines the perspectives of three functional area leads who work collaboratively during early-stage product development and device selection at GSK.
-
Accelerating Antibody Delivery With Surf Bio's Bryan Mazlish
1/29/2025
In this episode of Sit and Deliver, Surf Bio CEO Bryan Mazlish talks with host Tom von Gunden about subcutaneous delivery of monoclonal antibodies (mAbs) and other biologics via autoinjectors. Bryan shares with Tom the benefits of polymer-enabled administration of high-dose antibody treatments outside of infusion centers.
-
Integrating Development Processes For Combination Products
1/27/2025
The discussion highlights key aspects of a biopharma organization’s business and operations that must be effectively integrated when developing drugs and devices in tandem. These include imperatives such as establishing common terminology, applying QbD (Quaility by Design) principles, and managing supplier controls for providers of constituent parts.